INDV

NASDAQ · Pharmaceuticals

Indivior Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$35.53

+0.65 (+1.86%)

As of Sep 21, 9:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +36.5% upside

Low Target $40.68

Average Target $48.50

High Target $71.11

Current Price $35.53

Current
$35.53

Target
$48.50

$40.68 $48.50 avg $71.11

Scenario Analysis

Bear Case

$40.68

14.5%

Low target

Base Case

$48.50

+36.5%

Avg target

Bull Case

$71.11

+100.1%

High target

Risk/Reward

6.9x

Highly favorable

Price in Context

52-Week High

$42.81

-17.0% from high

52-Week Low

$22.22

+59.9% from low

50-Day SMA

$34.90

+1.8% vs SMA

200-Day SMA

$24.61

+44.4% vs SMA

RSI (14)

47.8

Neutral

Target vs 52W High

$48.50

+13.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%